Taiho Oncology, Inc.
Olek Czepla is currently the Executive Director of Data Management at Taiho Oncology, Inc. They have a strong background in data management, having held various director-level positions at companies such as Bayer HealthCare, Bellerophon Therapeutics, and Ikaria. Their education includes a Master's degree in Econometrics and Statistics from the University of Gdansk.
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com